- Home
- MDXG vs BHK Comparison
MDXG vs BHK Comparison
Compare MDXG & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- BHK
- Stock Information
- Founded
- MDXG 2006
- BHK 2001
- Country
- MDXG United States
- BHK United States
- Employees
- MDXG N/A
- BHK N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- BHK Finance Companies
- Sector
- MDXG Health Care
- BHK Finance
- Exchange
- MDXG Nasdaq
- BHK Nasdaq
- Market Cap
- MDXG 877.4M
- BHK 704.2M
- IPO Year
- MDXG N/A
- BHK N/A
- Fundamental
- Price
- MDXG $6.33
- BHK $9.52
- Analyst Decision
- MDXG Strong Buy
- BHK
- Analyst Count
- MDXG 2
- BHK 0
- Target Price
- MDXG $11.50
- BHK N/A
- AVG Volume (30 Days)
- MDXG 842.0K
- BHK 188.3K
- Earning Date
- MDXG 07-30-2025
- BHK 01-01-0001
- Dividend Yield
- MDXG N/A
- BHK 8.34%
- EPS Growth
- MDXG N/A
- BHK N/A
- EPS
- MDXG 0.27
- BHK 1.03
- Revenue
- MDXG $352,375,000.00
- BHK N/A
- Revenue This Year
- MDXG $9.55
- BHK N/A
- Revenue Next Year
- MDXG $11.43
- BHK N/A
- P/E Ratio
- MDXG $23.26
- BHK $10.42
- Revenue Growth
- MDXG 5.34
- BHK N/A
- 52 Week Low
- MDXG $5.47
- BHK $9.02
- 52 Week High
- MDXG $10.14
- BHK $11.09
- Technical
- Relative Strength Index (RSI)
- MDXG 47.21
- BHK 36.55
- Support Level
- MDXG $6.57
- BHK $9.60
- Resistance Level
- MDXG $6.85
- BHK $9.73
- Average True Range (ATR)
- MDXG 0.29
- BHK 0.07
- MACD
- MDXG 0.07
- BHK 0.01
- Stochastic Oscillator
- MDXG 39.50
- BHK 8.70
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About BHK Blackrock Core Bond Trust
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its managed assets in bonds that are investment-grade quality at the time of investment. The trust's investments will include a broad range of bonds, including corporate bonds, U.S. government and agency securities and mortgage-related securities.